TRVN:OTCMKTS
Trevena Inc
0,012 US$
0,00%
(0,00) 1D
6. 10., 10:01:51 GMT-4 · USD
search
Všechny symboly
| Symbol | Cena | Změna | Změna (%) |
|---|
insights_autoGenerování hlavních statistik pro TRVN…
Trž. kap.
10,37 tis.
Prům. obj.
182,00
Objem
2,00
52týd. max.
1,50 US$
52týd. min.
0,00 US$
Beta
1,07
Akcie v oběhu
864,00 tis.
Počet zaměstnanců
23
Trž. kap.
10,37 tis.
Prům. obj.
182,00
Objem
2,00
52týd. max.
1,50 US$
52týd. min.
0,00 US$
Beta
1,07
Akcie v oběhu
864,00 tis.
Počet zaměstnanců
23
Zpravodajské články
Z webových zdrojů a od partnerů z oblasti zpravodajství
MarketBeat
·
před 15 minutami
Axiom Intelligence Acquisition Corp 1 (NASDAQ:AXIN) Stock Short Interest Drops 85.7%
Simply Wall Street
·
před 19 minutami
Afya (AFYA) Could Be 15% Undervalued As Margin Expansion Fuels The Narrative
Crypto News
·
před 36 minutami
Evernorth completes merger with 473m XRP ahead of Nasdaq debut
Yahoo Finance
·
před 2 hodinami
Why “VOO and Chill” Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Profil
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz winner of the 2012 Nobel Prize in Chemistry and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects. Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and discovery-stage programs for chronic pain, migraine, and Parkinson's disease. Wikipedia
Informace o Trevena Inc
Generální ředitel-
Zaměstnanci23
Založeno2007
ÚstředíAtlanta, Georgie, Spojené státy americké
Odvětví-
Webtrevena.com